Key result
MMQ1 outperforms EQ-5D-5L in discriminating QoL variations in multimorbidity, particularly for poorer self-rated QoL.
Why the study?
It was unknown whether the recently validated English-language MMQ1 detects expected quality-of-life variations by individual characteristics and how it compares with EQ-5D-5L in detecting variations and discriminating quality-of-life levels.
Does the MMQ1 questionnaire better detect variations in QoL and discriminate between levels of self-rated QoL compared to EQ-5D-5L in patients with multimorbidity?
Does the MMQ1 questionnaire better detect variations in QoL and discriminate between levels of self-rated QoL compared to EQ-5D-5L in patients with multimorbidity?
The MMQ1 is superior to the EQ-5D-5L in detecting age-related variations in QoL and discriminating between different levels of self-rated QoL in patients with multimorbidity.
Hypothesis-generating for MMQ1 in multimorbidity QoL assessment; prospective validation needed before clinical adoption.
Background The Multimorbidity Questionnaire (MMQ1) is a patient-reported outcome measure assessing quality of life (QoL) in people with multimorbidity. An English-language version was recently validated for use in the United Kingdom. This study examines: (1) Whether MMQ1 detects expected variations in QoL according to individual characteristics; (2) How MMQ1 compares with EQ-5D-5L in detecting such variations, and in discriminating between different levels of QoL. Methods A postal survey was distributed to 2753 patients with multimorbidity. Relationships between MMQ1 and EQ-5D-5L with six independent variables (long-term condition count, mental-physical multimorbidity, deprivation, self-rated QoL, age and sex) were examined using linear regression analyses. Discriminative ability was assessed using Receiver Operating Characteristic curves and sample size calculations with respect to consecutive classes of self-rated QoL. Results 597 responses were received (22%). Respondents had a mean age of 69.5 years and 48% were men. Higher long-term condition count, the presence of mental-physical multimorbidity and increasing deprivation were associated with poorer QoL on both measures. In addition, three MMQ1 domains demonstrated age-related variations in QoL that were not detected using EQ-5D-5L. MMQ1 exhibited superior discriminative ability to EQ-5D-5L, especially in distinguishing between individuals with ‘Poor’ vs ‘Very Poor’ self-rated QoL, where EQ-5D-5L was particularly weak. Conclusion MMQ1 detected expected variations in QoL according to individual characteristics, supporting known-groups validity. It was superior to EQ-5D-5L in its ability to detect age-related variations in QoL and to discriminate between different levels of self-rated QoL. MMQ1 has the potential to improve the measurement of QoL in people with multimorbidity.
No takes yet. Share an insight, caveat, or question.
Sweeney et al. (2026) studied this question. MMQ1 showed superior discriminative ability compared to EQ-5D-5L in identifying variations in quality of life in patients with multimorbidity, particularly for poorer self-rated QoL.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: